Statistics
Publications
48
Citations
4.7K
H-Index
29
Active since
1988
Donald Banerji is an author at Novartis (United States) specializing in pulmonology, pharmacotherapy, and chronic obstructive pulmonary disease.
Publications per year
1988–2020
48
48
Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD
Jadwiga A. Wedzicha, Donald Banerji, Kenneth R. Chapman et al. · New England Journal of Medicine · 2016 · 870 citations · Full text
Jadwiga A. Wedzicha, Marc Decramer, Joachim H. Ficker et al. · The Lancet Respiratory Medicine · 2013 · 539 citations
Claus Vogelmeier, Eric Bateman, John Pallante et al. · The Lancet Respiratory Medicine · 2012 · 315 citations
Kenneth R. Chapman, John R. Hurst, Stefan Frent et al. · American Journal of Respiratory and Critical Care Medicine · 2018 · 262 citations
1–5 of 48